Eli Lilly and Company announced agreements to acquire potential targets, filing reports with the SEC.
7 reports, 7 independent
Updated Jul 17
Gone quiet
Reached 6 outlets in its first 24 hours
- Reports
- 7
- Developments
- 5
- Repetition
- 71%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Eli Lilly and Company announced agreements to acquire potential targets, filing reports with the SEC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Eli Lilly and Company plans to acquire Merida Biosciences for up to $2.8 billion in cash.Sub-event
- Eli Lilly announced a partnership for a digital patient care solution with Senderra, though market dynamics caused stock issues.Sub-event
- Eli Lilly acquired Scorpion Therapeutics from Axel Hoos, who previously served as SVP at GSK.Sub-event
Eli Lilly is pursuing acquisitions of potential targets and filing related reports with the SEC.1 source
Eli Lilly and Company is actively acquiring three vaccine developers to diversify its pipeline, with the President also involved in investor relations.1 source
Keep exploring
The entities involved
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Eli Lilly and Company plans to submit a drug candidate to the FDA for review and approval.
- A market rally was observed in the biotech sector, driven by positive cancer vaccine news, causing Eli Lilly shares to rise.
- An experimental drug, sourced from China, is under FDA scrutiny after marketing claims of being 'the ultimate good' and subsequent warnings were issued.
- Morgan Stanley increased its stake in Eli Lilly stock, and the company filed required reports with the SEC.
- Eli Lilly announced multiple new partnerships, including expanding Zepbound access with CVS Health, collaborating with Insilico Medicine, and investing in an AI lab with NVIDIA.
Coverage
Newest first; wire copies grouped- theepochtimes.com
- dailypolitical.com
- powderbulksolids.com
- tickerreport.com
- prnewswire.com
- Motley FoolDoes This $856 Million Investment Make Eli Lilly Stock a Buy? Eli Lilly is investing money to help a smaller biotech develop a new class of small-molecule drugs. This move is another in a long list o
- PR NewswireLilly and Verve announce expiration of Verve tender offer INDIANAPOLIS, July 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (NASDAQ: VERV) today announced tha